Arbutus Biopharma (ABUS) Free Cash Flow Growth (5y) (2018 - 2026)
Arbutus Biopharma (ABUS) Free Cash Flow Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - |
| 2 | Nanobiotix | 1,905.61 Bn | 1,905.55 Bn | - |
| 3 | Akari Therapeutics | 1,011.81 Bn | 1,011.81 Bn | - |
| 4 | BeOne Medicines | 467.29 Bn | 462.50 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.89 Bn | 115.65 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.28 Bn | 61.53 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.93 Bn | 62.93 Bn | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.64 Bn | 34.63 Bn | 959.66 Mn |
| 10 | Arbutus Biopharma | 857.43 Mn | 762.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.72% |
| Dec 31, 2025 | 20.95% |
| Sep 30, 2025 | 13.75% |
| Jun 30, 2025 | -12.17% |
| Mar 31, 2025 | 2.82% |
| Dec 31, 2024 | 4.96% |
| Sep 30, 2024 | 2.66% |
| Jun 30, 2024 | 4.06% |
| Mar 31, 2024 | -3.14% |
| Dec 31, 2023 | 0.01% |
| Sep 30, 2023 | -10.17% |
| Jun 30, 2023 | -2.50% |
| Mar 31, 2023 | -6.29% |
| Dec 31, 2022 | -10.21% |
| Sep 30, 2022 | -2.98% |
| Jun 30, 2022 | -20.12% |
| Mar 31, 2022 | 24.41% |
| Dec 31, 2021 | -2.45% |
| Sep 30, 2021 | -1.40% |
| Jun 30, 2021 | 3.79% |